Amazon.com Inc. (NASDAQ:AMZN) has launched online pharmacy and drug delivery services in Japan, expanding its presence in the company's global healthcare industry.
What Happened: Amazon has launched online prescription and medicine delivery services in Japan, in collaboration with approximately 2,500 drug stores nationwide. This initiative, introduced on Tuesday, will allow consumers to obtain their medications without visiting a physical pharmacy, reported Japan Today.
The Amazon Pharmacy service, already available outside Japan, enables consumers to receive electronic prescriptions after an online diagnosis through the CLINICS comprehensive healthcare app, or at a hospital or clinic. This service is primarily targeted at individuals with chronic health conditions who regularly require prescription refills.
Users of the service can receive guidance on medication administration through video chats with pharmacists, accessed via their Amazon accounts. They can also choose to have their medications delivered to their homes or pick them up from nearby pharmacies.
The Amazon Japan executive expressed the company's commitment to providing personalized healthcare services and plans to collaborate with more pharmacies, including small- and medium-sized ones.
Why It Matters: This recent development in Japan follows Amazon's expansion of its RxPass subscription service to over 50 million Medicare beneficiaries in the U.S. This expansion aimed to provide affordable access to medications for a broader audience.
Amazon's pharmacy unit has been making significant strides, including a partnership with Eli Lilly and Co. for the delivery of obesity drugs. This partnership marked a significant step in expanding access to vital medications, with Amazon Pharmacy becoming a third-party dispensing provider for LillyDirect Pharmacy Solutions.
However, Amazon's foray into the pharmaceutical industry was not without its challenges. The company had to implement major job cuts in its One Medical and Pharmacy units to save $100 million. Despite this, Amazon's pharmacy unit has continued to expand its services, with the recent launch in Japan being a significant step in its global expansion.
Price Action: Amazon's stock closed at $186.41 on Tuesday, up 2.11% for the day. In pre-market trading, the stock is slightly dipped by 0.059%. Year to date, Amazon's stock has risen by $36.48, reflecting a significant increase of 24.33%, according to data from Benzinga Pro.
- AMC Entertainment Announces Restructuring Of Debt Load, Adam Aron Says Box Office Challenges Are In 'Rearview Mirror'
Image Via Shutterstock
This story was generated using Benzinga Neuro and edited by Kaustubh Bagalkote
亚马逊公司（纳斯达克：AMZN）在日本推出了在线药房和药品送货服务，扩大了其在该公司全球医疗保健行业板块的存在。
发生了什么事：亚马逊在日本与全国约2500家药店合作推出了在线处方和药品送货服务。据日本今日消息报道，这项计划于周二推出，将允许消费者在不到实体药房的情况下获得药物。
亚马逊药房服务已在日本以外推出，消费者可以通过CLINICS综合医疗应用或在医院或诊所经过在线诊断后获得电子处方。该服务主要针对长期需要处方补充的患者。
服务的用户可以通过与药剂师的视频聊天来获得有关药物管理的指导，并通过其亚马逊账户访问。他们还可以选择将他们的药物送到家里或从附近的药店取走。
亚马逊日本的高管表示，该公司致力于提供个性化的医疗保健服务，并计划与更多的药店（包括中小型药店）合作。
在美国，亚马逊将其RxPass订阅服务扩展到了超过5000万名医保受益人。这个扩展旨在为更广泛的观众提供负担得起的药物。在日本的这一最新进展之前，亚马逊已经在医疗保健行业板块取得了重要的进展。
亚马逊的药房部门已经取得了重大进展，包括与礼来公司合作提供肥胖症药物的交付服务。这一合作标志着扩大获得重要药物的途径迈出了重要一步，亚马逊药房成为LillyDirect Pharmacy Solutions的第三方配药供应商。
然而，亚马逊进军制药业并不是没有挑战的。该公司不得不在One Medical和Pharmacy部门实施重大裁员以节省1亿美元。尽管如此，亚马逊的药房部门仍在不断扩展其服务，最近在日本的推出是其全球拓展的重大一步。
价格行动：周二，亚马逊的股票收于186.41美元，上涨了2.11％。在美股盘前交易中，该股票略有下跌，下跌了0.059％，根据Benzinga Pro的数据，亚马逊的股票今年以来已经上涨了36.48美元，反映了显着的涨幅24.33％。
- amc院线宣布重组债务负担，Adam Aron表示票房挑战已经是过去式。
图片来自shutterstock
本报道使用Benzinga Neuro生成，并由Kaustubh Bagalkote
